BLOOMFIELD, Conn., Dec. 12, 2023 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) was recognized by Dow Jones Sustainability Indices (DJSI) as a corporate sustainability industry leader for the seventh consecutive year. DJSI establishes benchmark standards for corporate sustainability practices and maintains both the Dow Jones Sustainability™ World Index (DJSI World) and the Dow Jones Sustainability North America Index (DJSI North America). The Cigna Group was recognized on both DJSI World and DJSI North America lists.
"We're incredibly proud to be recognized by DJSI for our commitment to transforming the health care ecosystem into one that is sustainable, accessible, and equitable," said Geneva Brown, vice president, environmental, social, and governance (ESG) and diversity, equity and inclusion (DEI). "At The Cigna Group, our mission centers around ensuring all people have the opportunity to achieve their full health and vitality potential regardless of social, economic, or environmental circumstances, and we will continue driving this work forward in support of all those we serve."
The Cigna Group's ESG vision underscores our pursuit in advancing better health for all and is organized under four connected pillars: Healthy Society, Healthy Workforce, Healthy Environment, and Healthy Company. Throughout the past year, The Cigna Group has made strides in advancing impactful work in each pillar:
The DJSI are float-adjusted market capitalization weighted indices that measure the performance of companies selected using environmental, social and governance (ESG) criteria. The DJSI were launched in 1999 as the pioneering series of global sustainability benchmarks available in the market. The index family is comprised of global, regional and country benchmarks.
About The Cigna Group
The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions, and has more than 165 million customer relationships around the world. Learn more at thecignagroup.com.
Media Contact
Madeline Sarver
(202) 615-1473
This email address is being protected from spambots. You need JavaScript enabled to view it.This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$330.13 |
Daily Change: | 0.69 0.21 |
Daily Volume: | 2,825,414 |
Market Cap: | US$91.830B |
January 30, 2025 October 31, 2024 September 12, 2024 September 12, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load